Ok check this out Sent this to Jeff yesterday. (I
Post# of 26
Sent this to Jeff yesterday. (IR at Neurotrope)
"Hello Jeff,
I hear Neurotrope is on schedule to report results before the end of the Month. Is that correct?
Most companies wait to report "bad" results until Friday's after close, so if the results are indeed "good", but won't be ready until after close Friday you guys should consider announcing you will hold the release until Monday May 1st.
Investors will be very nervous and the stock price will likely drop in anticipation of bad news if you guys don't release results tomorrow morning or before noon.
Got me fingers crossed for you. I hope the results are good."
They sent this PR out today:
NEUROTROPE BIOSCIENCE TO RELEASE RESULTS FROM PHASE 2 CLINICAL TRIAL IN MODERATE TO SEVERE ALZHEIMER’S DISEASE ON MAY 1, 2017
Company to Host Investor Conference Call
NEW YORK, April 28, 2017 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease, will issue a press release announcing results of top-line data from its 148 patient, Phase 2 clinical trial in moderate to severe Alzheimer's Disease, on Monday May 1, 2017, at 6:30 am, Eastern Time. A conference call will follow at 8:30 am Eastern Time on that date.
The dial-in information to access the live call is listed below:
Participant Toll Free Dial-In Number: (877) 245-7303
Participant International Dial-In Number: (478) 219-0731
Conference ID: 16070779
The dial-in information to access the call replay, available for 30 days after the live call, is listed below:
Replay Toll Free Dial-In Number: (800) 585-8367
Replay International Dial-In Number: ( 404) 537-3406
Conference ID: 16070779
Callers should dial in approximately 10 minutes before the live call begins.